Nordic Business Report-August 21, 2006-Orexo AB posts Q2 operating loss of SEK26.6m
(C)1994-2006 M2 COMMUNICATIONS LTD http://www.m2.com
The Swedish pharmaceutical company Orexo AB issued on Monday (21 August) its report for the second quarter, posting an operating loss of SEK26.6m, as compared to a loss of SEK16.6m in the second quarter of 2005.
The net turnover amounted to SEK5.1m, an increase from SEK1.7m in the second quarter last year.
One Swedish krona (SEK) is worth approximately 0.07 British pounds (GBP).
((Comments on this story may be sent to email@example.com))